Shuttle Pharmaceuticals (SHPH) News Today → Elon to Transform U.S. Economy? (From Porter & Company) (Ad) Free SHPH Stock Alerts $0.41 0.00 (0.00%) (As of 05/21/2024 ET) Add Compare Share Share HeadlinesStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 14, 2024 | finanznachrichten.deShuttle Pharmaceuticals Holdings, Inc.: Shuttle Pharma Provides First Quarter 2024 Corporate UpdateMay 14, 2024 | globenewswire.comShuttle Pharma Provides First Quarter 2024 Corporate UpdateMay 13, 2024 | investorplace.comSHPH Stock Earnings: Shuttle Pharmaceuticals Reported Results for Q1 2024April 23, 2024 | globenewswire.comShuttle Pharmaceuticals to Present at the Planet MicroCap Showcase: VEGAS 2024 on Wednesday, May 1, 2024 & 1x1 Meetings on Thursday, May 2, 2024April 3, 2024 | globenewswire.comShuttle Pharmaceuticals to Present at the Emerging Growth Conference on April 4, 2024March 22, 2024 | finanznachrichten.deShuttle Pharmaceuticals Holdings, Inc.: Shuttle Pharma Provides Fourth Quarter 2023 Corporate UpdateMarch 22, 2024 | finance.yahoo.comShuttle Pharma Provides Fourth Quarter 2023 Corporate UpdateMarch 22, 2024 | msn.comSHPH Stock Earnings: Shuttle Pharmaceuticals Reported Results for Q4 2023March 5, 2024 | globenewswire.comShuttle Pharmaceuticals to Present at the Emerging Growth Conference on March 6, 2024February 13, 2024 | finance.yahoo.comShuttle Pharma Announces Its Intent to Pursue a Rights OfferingFebruary 6, 2024 | msn.comShuttle Pharmaceuticals Acquires Promising Prostate Cancer TechnologyFebruary 6, 2024 | msn.comShuttle Pharmaceuticals Bolsters Investor Relations with New PartnershipJanuary 23, 2024 | finance.yahoo.comShuttle Pharma to Participate in a Fireside Chat at the Lytham Partners 2024 Investor Select Conference on February 1, 2024January 8, 2024 | finance.yahoo.comShuttle Pharmaceuticals Receives FDA Approval to Proceed with Phase II Clinical Trial of Ropidoxuridine for Treatment of Patients with GlioblastomaDecember 11, 2023 | finance.yahoo.comShuttle Pharmaceuticals Submits IND Application to the U.S. FDA for Ropidoxuridine Phase II Clinical Trial for Patients with GlioblastomaNovember 30, 2023 | finance.yahoo.comShuttle Pharmaceuticals to Present at the Emerging Growth Conference on December 7, 2023November 14, 2023 | msn.comShuttle Pharmaceuticals reports Q3 resultsNovember 14, 2023 | finance.yahoo.comShuttle Pharmaceuticals Provides Third Quarter 2023 Corporate UpdateOctober 31, 2023 | finance.yahoo.comShuttle Pharma Advances Prostate Cancer Predictive Biomarker Program Through Exclusive License AgreementOctober 10, 2023 | finance.yahoo.comShuttle Pharma to Participate in the Lytham Partners Fall 2023 Investor ConferenceSeptember 25, 2023 | marketwatch.comShuttle Pharma Gets FDA Letter With Positive Feedback for RopidoxuridineSeptember 25, 2023 | finance.yahoo.comShuttle Pharma Announces Results of Pre-IND Meeting with FDA for Ropidoxuridine Phase II Clinical Trial for Patients with GlioblastomaSeptember 13, 2023 | finance.yahoo.comShuttle Pharma Participates in Hampton University Proton Therapy Institute Prostate Cancer & Men's Health FairSeptember 11, 2023 | finance.yahoo.comShuttle Pharma Expands Patent Coverage on HDAC Inhibitor PlatformAugust 29, 2023 | finance.yahoo.comShuttle Pharma's Selective HDAC6 Inhibitor Shown to Stimulate Innate Immune Response in Pre-clinical Studies, as Reported in Molecular Cancer TherapeuticsAugust 15, 2023 | finance.yahoo.comShuttle Pharmaceuticals Provides Second Quarter 2023 Corporate UpdateAugust 11, 2023 | fool.comShuttle Pharmaceuticals (NASDAQ: SHPH)August 3, 2023 | finance.yahoo.comShuttle Pharmaceuticals Completes Manufacturing of Active Pharmaceutical Ingredient (API) for Use in Clinical TrialMay 27, 2023 | benzinga.comShuttle Pharmaceuticals Q1 EPS $(0.07), Same YoYMay 26, 2023 | finance.yahoo.comShuttle Pharmaceuticals Provides First Quarter 2023 Corporate UpdateMay 17, 2023 | finance.yahoo.comShuttle Pharmaceuticals to Participate in the Lytham Partners Spring 2023 Investor ConferenceApril 5, 2023 | marketbeat.comWhy Did Bullfrog AI Stock Jump More Than 50%? (SHPH)Trading volume and share price for BFRG took significant leaps forward on news the digital biopharmaceutical company will partner with Johns Hopkins University.March 22, 2023 | finance.yahoo.comShuttle Pharmaceuticals Enters Research Agreement with Georgetown University for Testing of Small Molecule Radiation Sensitizers and Immune Activation CandidatesMarch 9, 2023 | finance.yahoo.comShuttle Pharmaceuticals Engages UI Pharmaceuticals for Formulation and Clinical Batch Manufacture of Ropidoxuridine for Brain Tumor Clinical TrialFebruary 23, 2023 | finance.yahoo.comShuttle Pharmaceuticals Expands Laboratory Space to Advance Drug Development Pipeline and Diagnostic CapabilitiesFebruary 6, 2023 | proactiveinvestors.comShuttle Pharmaceuticals making progress with Phase II clinical studyJanuary 27, 2023 | finance.yahoo.comShuttle Pharmaceuticals to Present at Lytham Partners Investor Select Conference on January 31January 25, 2023 | seekingalpha.comSHPH Shuttle Pharmaceuticals Holdings, Inc.January 17, 2023 | finance.yahoo.comShuttle Pharmaceuticals to Ring Nasdaq Opening Bell on Wednesday, January 18, 2023January 12, 2023 | finance.yahoo.comShuttle Pharmaceuticals Announces Private Placement of $4.3 Million of Senior Secured Convertible Note and WarrantsDecember 6, 2022 | finance.yahoo.comShuttle Pharmaceuticals Manuscript Published in Cancer Research CommunicationsDecember 3, 2022 | seekingalpha.comRadiation therapy drug maker Shuttle Pharmaceuticals stock rockets 71%November 15, 2022 | finance.yahoo.comShuttle Pharmaceuticals Provides Third Quarter 2022 Corporate UpdateNovember 3, 2022 | finance.yahoo.comShuttle Pharmaceuticals Engages Theradex Oncology in Preparation for Clinical StudyNovember 1, 2022 | finance.yahoo.comShuttle Pharmaceuticals Appoints Bette Jacobs to its Board of DirectorsOctober 6, 2022 | ca.finance.yahoo.comShuttle Pharmaceuticals Holdings, Inc. (SHPH)September 22, 2022 | wsj.comShuttle Pharmaceuticals Holdings Inc.September 20, 2022 | finance.yahoo.comShuttle Pharmaceuticals Enters into Manufacturing Agreement for RopidoxuridineSeptember 17, 2022 | benzinga.comShuttle Pharmaceuticals Stock (NASDAQ:SHPH), Analyst Ratings, Price Targets, PredictionsSeptember 16, 2022 | marketbeat.comTrading was temporarily halted for "SHPH" at 11:09 AM with a stated reason of "LULD pause." Get Shuttle Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for SHPH and its competitors with MarketBeat's FREE daily newsletter. Email Address Obama’s Forever Term [exposed] (Ad)Over a decade ago, I tried to warn you... Because the same forces are once again brewing… and what’s coming next will forever reshape everything you think you know about America. Start streaming it now at no cost here SHPH Media Mentions By Week SHPH Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. SHPH News Sentiment▼0.460.43▲Average Medical News Sentiment SHPH News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. SHPH Articles This Week▼00▲SHPH Articles Average Week Get Shuttle Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for SHPH and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: KTTA News CVKD News HEPA News TENX News VCNX News VIRI News BFRI News PULM News ASLN News OGEN News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:SHPH) was last updated on 5/22/2024 by MarketBeat.com Staff From Our PartnersExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersWarren Buffett's "mystery stock"Stansberry ResearchNew Options need New Trading StrategiesNetpicksObama’s Forever Term [exposed]Porter & CompanyTrump’s second term “playbook” leaked?Paradigm PressYou won’t see these trades on TVProsper Trading AcademyThis could mean the end of the U.S dollar…Colonial MetalsMust-See: Elon’s New Invention is Absolutely InsaneInvestorPlace Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Shuttle Pharmaceuticals Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
